|
Sign In to gain access to subscriptions and/or personal tools.
|
Achieving acceptable adiposity
Henry Purcell
Obesity Research Group, Department of Histopathology, Royal Brompton Hospital, London, UK
Caroline Day
Diabetes Research Group, School of Life and Health Sciences, Aston University, Birmingham, UK, cday{at}mededuk.com
References
- World Health Organization. Global strategy on diet, physical activity and health. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/ (Accessed July 2008)
- Centers for Disease Control and Prevention. Overweight and obesity. http://www.cdc.gov/nccdphp/dnpa/obesity/index.htm (Accessed July 2008)
- McPherson K., March T., Brown M. Foresight. Tackling obesities: Future choices - modelling future trends in obesity and their impact on health. 2nd Edition. London: Department for Innovation, Universities and Skills, October 2007. http://www.foresight.gov.uk/Obesity/14.pdf (Accessed July 2008)
- Eckel RH, Grundy SM, Zimmet PZ The metabolic syndrome. Lancet 2005; 365:1415-28.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Medical Research Council-human nutrition research. http://www.mrchnr.cam.ac.uk/research/obesity/diabetes.html (Accessed July 2008)
- Diabetes UK Type 2 diabetes & obesity: a heavy burden. March 2005. http://www.diabetes.org.uk/Documents/Reports/obesity_0305.doc (Accessed July 2008)
- UK National Audit Office. Tackling obesity in England 2003. http://www.nao.org.uk/publications/nao_reports/00-01/0001220.pdf (Accessed May 2008)
- House of Commons Health Committee. Obesity 2004. Third report of session 2003-4. May 2004. http://www.publications.parliament.uk/pa/cm200304/cmselect/cmhealth/23/23.pdf (Accessed July 2008)
- Day C., Bailey CJ Pharmacological approaches to reduce adiposity. Br J Diabetes Vasc Dis 2006; 6:121-5.[Abstract/Free Full Text]
- Wilding J., Finer N. Weight management and cardiovascular disease: implications of recent and ongoing clinical trials. Br J Diabetes Vasc Dis 2008; 8:170-176[Abstract/Free Full Text]
- Nice Rimonabant for the treatment of overweight and obese adults. NICE Technology appraisal 144. London: NICE, 2008: http://www.nice.org.uk/nicemedia/pdf/TA144Guidance.pdf (Accessed July 2008).
- Branca F, Nikogosian H, Lobstein T (eds.). The Challenge of Obesity in the WHO European Region and the Strategies for Response. Summary. Copenhagen: WHO, 2007: 76. http://www.euro.who.int/document/e89858.pdf (Accessed July 2008).
- Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Paediatr Endocrin Metab 2000; 13:1395-1402
- Agwu JC Screening for type 2 diabetes mellitus in children and adolescents. Br J Diabetes Vasc Dis 2008; 8:163-168[Abstract/Free Full Text]
- Song SH Early-onset type 2 diabetes mellitus: a condition with elevated cardiovascular risk? Br J Diabetes Vasc Dis 2008; 8:61-5.[Abstract/Free Full Text]
- Nice. Obesity: Guidance on the Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. NICE clinical guideline 43. London: NICE, 2006.
- Matyka K., Malik S. Management of the obese child- application of NICE guidelines 2006. Br J Diabetes Vasc Dis 2008; 8:178-182
- Butler S. Hudibras with notes by TR Nash, part II, canto.II, line 504, p.236. D.Appleton & Company, New York, 1856.
The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 4,
159-161 (2008)
DOI: 10.1177/1474651408096947

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|